Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
Cancers · 2024
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 1 country.
Aneta Szudy-SzczyrekDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0003-2352-394X
Radosław MlakBody Composition Research Laboratory, Department of Preclinical Sciences, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0001-7399-8340
Marcin MazurekDepartment of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0002-4040-0450
Tomasz KrajkaDivision of Mathematics, Department of Production Computerisation and Robotisation, Lublin University of Technology, 20-618 Lublin, Poland.ORCID 0000-0001-6513-1253
Sylwia ChocholskaDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0002-5001-9258
Paulina BitkowskaDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.
Marta JutrzenkaCollegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.ORCID 0000-0001-7266-1586
Michał SzczyrekDepartment of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.
Iwona Homa-MlakDepartment of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland.
Andrzej KrajkaInstitute of Computer Science, Maria Curie-Sklodowska University, 20-033 Lublin, Poland.ORCID 0000-0002-3506-4616
Teresa Małecka-MassalskaDepartment of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland.
Marek HusDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.
Medical University of Lublin · PLLublin University of Technology · PLMaria Curie-Skłodowska University · PLUniversity of Warmia and Mazury in Olsztyn · PL
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
backgroundThe
methodsThe study group consisted of 128 patients with de novo MM. EDTA venous blood samples were collected prior to the treatment. The SNPs were analyzed by Real-Time PCR with the use of specific Taqman probes.
resultsMultivariable analysis revealed that variables independently associated with shorter progression-free survival (PFS) included thrombocytopenia,
conclusionThe evaluation of the SNP 686C > T of the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The TT Genotype of the · full record | OpenQuestion